Activation of a cGAS-STING-mediated immune response predicts response to neoadjuvant chemotherapy in early breast cancer
出版年份 2021 全文链接
标题
Activation of a cGAS-STING-mediated immune response predicts response to neoadjuvant chemotherapy in early breast cancer
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 126, Issue 2, Pages 247-258
出版商
Springer Science and Business Media LLC
发表日期
2021-11-02
DOI
10.1038/s41416-021-01599-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bernard Fisher, MD: In Memoriam (1918–2019)
- (2020) Nancy E. Davidson CANCER RESEARCH
- Pembrolizumab for Early Triple-Negative Breast Cancer
- (2020) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Maximizing Breast Cancer Therapy with Awareness of Potential Treatment‐Related Blood Disorders
- (2020) Henry G. Kaplan et al. ONCOLOGIST
- Improving the Diagnostic Accuracy of the PD-L1 Test with Image Analysis and Multiplex Hybridization
- (2020) Matthew P. Humphries et al. Cancers
- Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
- (2020) Elizabeth A Mittendorf et al. LANCET
- Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
- (2019) Sherene Loi et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
- (2019) Leonie Voorwerk et al. NATURE MEDICINE
- PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer
- (2019) Constantia Pantelidou et al. Cancer Discovery
- The Cytoplasmic DNA Sensor cGAS Promotes Mitotic Cell Death
- (2019) Christian Zierhut et al. CELL
- Validation of the DNA Damage Immune Response Signature in Patients With Triple-Negative Breast Cancer From the SWOG 9313c Trial
- (2019) Priyanka Sharma et al. JOURNAL OF CLINICAL ONCOLOGY
- Anthracycline Use for Early Stage Breast Cancer in the Modern Era: a Review
- (2018) Sakshi Jasra et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Long-term effect of epirubicin on incidence of heart failure in women with breast cancer: insight from a randomized clinical trial
- (2018) Ann Banke et al. EUROPEAN JOURNAL OF HEART FAILURE
- Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
- (2018) Carsten Denkert et al. LANCET ONCOLOGY
- TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
- (2018) Daniele V. F. Tauriello et al. NATURE
- Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
- (2018) Andrew Tutt et al. NATURE MEDICINE
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- cGAS surveillance of micronuclei links genome instability to innate immunity
- (2017) Karen J. Mackenzie et al. NATURE
- Mitotic progression following DNA damage enables pattern recognition within micronuclei
- (2017) Shane M. Harding et al. NATURE
- Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
- (2017) Maria Vittoria Dieci et al. SEMINARS IN CANCER BIOLOGY
- Topoisomerase II Inhibitors Induce DNA Damage-Dependent Interferon Responses Circumventing Ebola Virus Immune Evasion
- (2017) Priya Luthra et al. mBio
- FAK-inhibition opens the door to checkpoint immunotherapy in Pancreatic Cancer
- (2017) Stefan N. Symeonides et al. Journal for ImmunoTherapy of Cancer
- Gene expression markers of Tumor Infiltrating Leukocytes
- (2017) Patrick Danaher et al. Journal for ImmunoTherapy of Cancer
- Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression
- (2017) Matjaz Rokavec et al. Scientific Reports
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
- (2016) Eileen E. Parkes et al. JNCI-Journal of the National Cancer Institute
- Predictive value of angiogenesis-related gene profiling in patients with HER2-negative metastatic breast cancer treated with bevacizumab and weekly paclitaxel
- (2016) Marta Mendiola et al. Oncotarget
- Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
- (2016) Eileen E. Parkes et al. JNCI-Journal of the National Cancer Institute
- DNA Damage Primes the Type I Interferon System via the Cytosolic DNA Sensor STING to Promote Anti-Microbial Innate Immunity
- (2015) Anetta Härtlova et al. IMMUNITY
- Activation and Regulation of DNA-Driven Immune Responses
- (2015) Søren R. Paludan MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Natural and therapy-induced immunosurveillance in breast cancer
- (2015) Guido Kroemer et al. NATURE MEDICINE
- The Molecular Signatures Database Hallmark Gene Set Collection
- (2015) Arthur Liberzon et al. Cell Systems
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- Identification and Validation of an Anthracycline/Cyclophosphamide–Based Chemotherapy Response Assay in Breast Cancer
- (2014) Jude M. Mulligan et al. JNCI-Journal of the National Cancer Institute
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity
- (2014) Denise M. Wolf et al. PLoS One
- Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity
- (2013) Marzia Lotrionte et al. AMERICAN JOURNAL OF CARDIOLOGY
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints
- (2012) Debora Fumagalli et al. LANCET ONCOLOGY
- Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer
- (2012) Stefan Bentink et al. PLoS One
- An immune-active tumor microenvironment favors clinical response to ipilimumab
- (2011) Rui-Ru Ji et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Microarray meta-analysis defines global angiogenesis-related gene expression signatures in human carcinomas
- (2011) Mario Anders et al. MOLECULAR CARCINOGENESIS
- Adjuvant Trastuzumab in HER2-Positive Breast Cancer
- (2011) Dennis Slamon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
- (2011) David G. DeNardo et al. Cancer Discovery
- Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules
- (2010) Andrew E Teschendorff et al. BMC CANCER
- The Macrophage Colony-Stimulating Factor 1 Response Signature in Breast Carcinoma
- (2009) A. H. Beck et al. CLINICAL CANCER RESEARCH
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer
- (2008) Alberto Calabrò et al. BREAST CANCER RESEARCH AND TREATMENT
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now